Correction to: Comparison of the Efficacy and Safety of Tofacitinib and Apremilast in Patients with Active Psoriatic Arthritis: A Bayesian Network Meta-Analysis of Randomized Controlled Trials (Clinical Drug Investigation, (2019), 39, 5, (421-428), 10.1007/s40261-019-00765-w)

Research output: Contribution to journalComment/debate

Abstract

The original version of this article unfortunately contained a mistake. The corresponding author was incorrect.

Original languageEnglish
Number of pages1
JournalClinical Drug Investigation
Volume39
Issue number7
DOIs
Publication statusPublished - 2019 Jul 1

Fingerprint

Psoriatic Arthritis
Randomized Controlled Trials
Safety
Pharmaceutical Preparations
tofacitinib
apremilast
Network Meta-Analysis

ASJC Scopus subject areas

  • Pharmacology (medical)

Cite this

@article{00656fb66bec4519a179c47d18d8bdaf,
title = "Correction to: Comparison of the Efficacy and Safety of Tofacitinib and Apremilast in Patients with Active Psoriatic Arthritis: A Bayesian Network Meta-Analysis of Randomized Controlled Trials (Clinical Drug Investigation, (2019), 39, 5, (421-428), 10.1007/s40261-019-00765-w)",
abstract = "The original version of this article unfortunately contained a mistake. The corresponding author was incorrect.",
author = "Song, {Gwan Gyu} and Lee, {Young Ho}",
year = "2019",
month = "7",
day = "1",
doi = "10.1007/s40261-019-00817-1",
language = "English",
volume = "39",
journal = "Clinical Drug Investigation",
issn = "1173-2563",
publisher = "Adis International Ltd",
number = "7",

}

TY - JOUR

T1 - Correction to

T2 - Comparison of the Efficacy and Safety of Tofacitinib and Apremilast in Patients with Active Psoriatic Arthritis: A Bayesian Network Meta-Analysis of Randomized Controlled Trials (Clinical Drug Investigation, (2019), 39, 5, (421-428), 10.1007/s40261-019-00765-w)

AU - Song, Gwan Gyu

AU - Lee, Young Ho

PY - 2019/7/1

Y1 - 2019/7/1

N2 - The original version of this article unfortunately contained a mistake. The corresponding author was incorrect.

AB - The original version of this article unfortunately contained a mistake. The corresponding author was incorrect.

UR - http://www.scopus.com/inward/record.url?scp=85067650117&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85067650117&partnerID=8YFLogxK

U2 - 10.1007/s40261-019-00817-1

DO - 10.1007/s40261-019-00817-1

M3 - Comment/debate

C2 - 31197660

AN - SCOPUS:85067650117

VL - 39

JO - Clinical Drug Investigation

JF - Clinical Drug Investigation

SN - 1173-2563

IS - 7

ER -